The Clinical Predictors That Facilitate a Clinician's Decision to Order Genetic Testing for Rett Syndrome
- PMID: 27473651
- DOI: 10.1016/j.pediatrneurol.2016.06.016
The Clinical Predictors That Facilitate a Clinician's Decision to Order Genetic Testing for Rett Syndrome
Abstract
Background: Rett syndrome is a common genetic cause of intellectual disability in girls caused by a mutation in the MECP2 gene. Diagnosis is based on clinical criteria. The aim was to compare the frequencies of the clinical criteria in patients with and without MECP2 mutations.
Methods: We performed a retrospective review at a children's hospital of patients who underwent MECP2 testing from 2008 to 2013. Logistic regression was performed to determine which criteria were most predictive of MECP2 status.
Results: Of 169 patients who met inclusion criteria, 46 (27.2%) were MECP2 positive. Loss of language skills (MECP2+ 100% versus MECP2- 87.8%; P = 0.012) was the most common finding among both groups. Other main criteria were more common in MECP2 patients: gait abnormalities (84.8% versus 27.6%; P < 0.0001); stereotypic hand movements (76.1% versus 15.5%; P < 0.0001); loss of hand skills (71.7% versus 4.9%; P < 0.0001). Logistic regression analysis including all four criteria demonstrated language loss was not predictive.
Conclusions: Loss of hand skills resulted in the highest odds of having a positive genetic test. Gait abnormalities and stereotypic hand movements were also strong predictors of MECP2+ testing. Many individuals with language delay had genetic testing; however, this is the least specific of the major criteria. These findings have implications for which patients should have genetic testing.
Keywords: MECP2 gene test; Rett syndrome; cognitive/behavioral disorders; genetic testing for Rett; stereotypic hand movements.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.Neurology. 2007 Apr 10;68(15):1183-7. doi: 10.1212/01.wnl.0000259086.34769.78. Neurology. 2007. PMID: 17420401
-
MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.J Hum Genet. 2016 Jul;61(7):617-25. doi: 10.1038/jhg.2016.19. Epub 2016 Mar 17. J Hum Genet. 2016. PMID: 26984561
-
Spectrum of MECP2 mutations in New Zealand Rett syndrome patients.N Z Med J. 2009 Jun 5;122(1296):21-8. N Z Med J. 2009. PMID: 19652677
-
[Rett syndrome: clinical and molecular aspects].Cas Lek Cesk. 2007;146(8):647-52. Cas Lek Cesk. 2007. PMID: 17874730 Review. Czech.
-
Molecular diagnosis of Rett syndrome.J Child Neurol. 2005 Sep;20(9):732-6. doi: 10.1177/08830738050200090601. J Child Neurol. 2005. PMID: 16225827 Review.
Cited by
-
Development of the Tailored Rett Intervention and Assessment Longitudinal (TRIAL) database and the Rett Evaluation of Symptoms and Treatments (REST) Questionnaire.BMJ Open. 2017 Jun 21;7(6):e015342. doi: 10.1136/bmjopen-2016-015342. BMJ Open. 2017. PMID: 28637735 Free PMC article.
-
Novel FOXG1 mutations in Chinese patients with Rett syndrome or Rett-like mental retardation.BMC Med Genet. 2017 Aug 29;18(1):96. doi: 10.1186/s12881-017-0455-y. BMC Med Genet. 2017. PMID: 28851325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous